Der p2 activates airway smooth muscle cells in a TLR2/ MyD88-dependent manner to induce an inflammatory response

Journal of Cellular Physiology

Volumn 220, Issue 2, 2009, Pages 311-318

  Chiou, Ya Ling ^a   Lin, Ching Yuang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DER P2 ALLERGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; CYTOKINE; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 2; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYD88 PROTEIN, RAT; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TH2 CELL; ANIMAL; ASTHMA; CELL CULTURE; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; RAT; RESPIRATORY SYSTEM;

DERMATOPHAGOIDES PTERONYSSINUS; PYROGLYPHIDAE;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CELLS, CULTURED; CYTOKINES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MYELOID DIFFERENTIATION FACTOR 88; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROTEIN ISOFORMS; RATS; RESPIRATORY SYSTEM; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS;

EID: 67649366022     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21764     Document Type: Article

References (52)

1. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, Pulendran B. 2003. Cutting edge: Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171:4984-4989.
2. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
3. Becker A, Hessenius C, Bhargava S, Grotzinger C, Licha K, Schneider-Mergener J, Wiedenmann B, Semmler W. 2000. Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumors. Ann NY Acad Sci 921:275-278.
4. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. 2006. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24:353-389.
5. Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N, Howarth P, Richards DH, Williams M, Pauwels R. 2005. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 60:875-881.
6. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. 2006. The link between fungi and severe asthma: A summary of the evidence. Eur Respir J 27:615-626.
7. Didierlaurent A, Ferrero I, Otten LA, Dubois B, Reinhardt M, Carlsen H, Blomhoff R, Akira S, Kraehenbuhl JP, Sirard JC. 2004. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol 172:6922-6930.
8. Doganci A, Sauer K, Karwot R, Finotto S. 2005. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol 28:257-270.
9. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196:1645-1651.
10. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78-83.
11. Gangloff SC, Guenounou M. 2004. Toll-like receptors and immune response in allergic disease. Clin Rev Allergy Immunol 26:115-125.
12. Gershwin LJ. 2007. Effects of allergenic extracts on airway epithelium. Curr Allergy Asthma Rep 7:357-362.
13. Grunstein MM, Veler H, Shan X, Larson J, Grunstein JS, Chuang S. 2005. Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle. J Allergy Clin Immunol 116:94-101.
14. Hallsworth MP, Twort CH, Lee TH, Hirst SJ. 2001. beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. Br J Pharmacol 132:729-741.
15. Herbert CA, King CM, Ring PC, Holgate ST, Stewart GA, Thompson PJ, Robinson C. 1995. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der pl. Am J Respir Cell Mol Biol 12:369-378.
16. Herrick CA, Bottomly K. 2003. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 3:405-412.
17. Hoebe K, Janssen E, Beutler B. 2004. The interface between innate and adaptive immunity. Nat Immunol 5:971-974.
18. Horng T, Barton GM, Flavell RA, Medzhitov R. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-333.
19. Hsu MH, Chen CJ, Kuo SC, Chung JG, Lai YY, Teng CM, Pan SL, Huang LJ. 2007. 2-(3-Fluorophenyl)-6-methoxyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (YJC-1) induces mitotic phase arrest in A549 cells. Eur J Pharmacol 559:14-20.
20. Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T, Akira S. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int Immunol 14:695-700.
21. Lee JS, Kim IS, Ryu JS, Yun CY. 2008. House dust mite, Dermatophagoides pteronissinus increases expression of MCP-1, IL-6, and IL-8 in human monocytic THP-1 cells. Cytokine 42:365-371.
22. Li XY, Gilmour PS, Donaldson K, MacNee W. 1996. Free radical activity and proinflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax 51:1216-1222.
23. Li GP, Liu ZG, Qiu J, Ran PX, Zhong NS. 2005. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model. Chin Med J (Engl) 118:534-540.
24. Liu YH, Tsai CF, Kao MC, Lai YL, Tsai JJ. 2003. Effectiveness of Dp2 nasal therapy for Dp2-induced airway inflammation in mice: Using oral Ganoderma lucidum as an immunomodulator. J Microbiol Immunol Infect 36:236-242.
25. Micillo E, Bianco A, D'Auria D, Mazzarella G, Abbate GF. 2000. Respiratory infections and asthma. Allergy 55:42-45.
26. Morris GE, Whyte MK, Martin GF, Jose PJ, Dower SK, Sabroe I. 2005. Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. AmJ Respir Crit Care Med 171:814-822.
27. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells. J Immunol 164:5998-6004.
28. Nakamichi K, Saiki M, Sawada M, Takayama-Ito M, Yamamuro Y, Morimoto K, Kurane I. 2005. Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J Virol 79:11801-11812.
29. Odaka M, Matsukura S, Kuga H, Kokubu F, Kasama T, Kurokawa M, Kawaguchi M, Ieki K, Suzuki S, Watanabe S, Homma T, Takeuchi H, Nohtomi K, Schleimer RP, Adachi M. 2007. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells. Int Arch Allergy Immunol 143:84-88.
30. Oliver BG, Black JL. 2006. Airway smooth muscle and asthma. Allergol Int 55:215-223.
31. Parker LC, Whyte MK, Vogel SN, Dower SK, Sabroe I. 2004. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol 172:4977-4986.
32. Peake HL, Currie AJ, Stewart GA, McWilliam AS. 2003. Nitric oxide production by alveolar macrophages in response to house dust mite fecal pellets and the mite allergens, Der p 1 and Der p 2. J Allergy Clin Immunol 112:531-537.
33. Pype JL, Dupont LJ, Menten P, Van Coillie E, Opdenakker G, Van Damme J, Chung KF, Demedts MG, Verleden GM. 1999. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 21:528-536.
34. Qiu J, Li GP, Liu ZG, Ran PX, Zhong NS. 2006. DNA vaccine encoding Der p2 allergen down-regulates STAT6 expression in mouse model of allergen-induced allergic airway inflammation. Chin Med J (Engl) 119:185-190.
35. Rabito FA, Iqbal S, Holt E, Grimsley LF, Islam TM, Scott SK. 2007. Prevalence of indoor allergen exposures among New Orleans children with asthma. J Urban Health 84:782-792.
36. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, Broide DH, Raz E. 2004. Cutting edge: Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172:2739-2743.
37. Ritz SA, Stampfli MR, Davies DE, Holgate ST, Jordana M. 2002. On the generation of allergic airway diseases: From GM-CSF to Kyoto. Trends Immunol 23:396-402.
38. Roche N, Chinet TC, Huchon GJ. 1997. Allergic and nonallergic interactions between house dust mite allergens and airway mucosa. Eur Respir J 10:719-726.
39. Rose CE, Jr., Sung SS, Fu SM. 2003. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10:273-288.
40. Shan X, Hu A, Veler H, Fatma S, Grunstein JS, Chuang S, Grunstein MM. 2006. Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling. Am J Physiol Lung Cell Mol Physiol 291:L324-333.
41. Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF. 2006. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 118:641-648.
42. Syed MM, Phulwani NK, Kielian T. 2007. Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia. J Neurochem 103:1461-1471.
43. Tsai JJ, Shen HD, Chua KY. 2000. Purification of group 2 Dermatophagoides pteronyssinus allergen and prevalence of its specific IgE in asthmatics. Int Arch Allergy Immunol 121:205-210.
44. Tsai JJ, Liu YH, Shen HD, Huang SH, Han SH. 2002. Prevention of Der p2-induced allergic airway inflammation by Mycobacterium-bacillus Calmette Guerin. J Microbiol Immunol Infect 35:152-158.
45. Velasco G, Campo M, Manrique OJ, Bellou A, He H, Arestides RS, Schaub B, Perkins DL, Finn PW. 2005. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 32:218-224.
46. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166:249-255.
47. Wagner H. 2001. Toll meets bacterial CpG-DNA. Immunity 14:499-502.
48. Wang SZ, Xu H, Wraith A, Bowden JJ, Alpers JH, Forsyth KD. 1998. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur Respir J 12:612-618.
49. Wynn TA. 2003. IL-13 effector functions. Annu Rev Immunol 21:425-456.
50. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324-329.
51. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S. 2003. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4:1144-1150.
52. Yamamoto M, Takeda K, Akira S. 2004. TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 40:861-868.